Masafumi Haraguchi

Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings

Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi et al. · Cancers · 2019 · 53 citations · Full text

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma

Ryu Sasaki, Kazuyoshi Nagata, Masanori Fukushima et al. · Cancers · 2022 · 37 citations · Full text

Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP‑1 cells

Yuri Miyazoe, Satoshi Miuma, Hisamitsu Miyaaki et al. · Biomedical Reports · 2020 · 21 citations · Full text

High serum concentrations of growth differentiation factor-15 and their association with Crohn’s disease and a low skeletal muscle index

Hiroyuki Yamamoto, Fuminao Takeshima, Masafumi Haraguchi et al. · Scientific Reports · 2022 · 19 citations · Full text

Immunology, Gastroenterology, Pathology +22

Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis

Masafumi Haraguchi, Hisamitsu Miyaaki, Tatsuki Ichikawa et al. · Hepatology International · 2016 · 17 citations

Metabolic Syndrome, Sleep, Sleep Disorder +12